Upgrade to SI Premium - Free Trial

MetaVia (MTVA)

1.58 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

MetaVia Inc. (MTVA) Tops Q2 EPS by 73c August 7, 2026 8:56 AM - StreetInsider Form 10-Q MetaVia Inc. For: Jun 30 August 6, 2026 4:34 PM - SEC Filing Form 8-K MetaVia Inc. For: Aug 06 August 6, 2026 4:07 PM - SEC Filing MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 6, 2026 4:05 PM - PR NewsWire H.C. Wainwright Reiterates Buy Rating on MetaVia (MTVA) July 10, 2026 6:50 AM - StreetInsider Form 8-K MetaVia Inc. For: Jul 09 July 9, 2026 8:36 AM - SEC Filing MetaVia completes dose titration in Phase 1 Part 3 obesity trial July 9, 2026 8:31 AM - StreetInsider MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity July 9, 2026 8:31 AM - PR NewsWire Form 8-K MetaVia Inc. For: Jul 02 July 2, 2026 4:07 PM - SEC Filing Form 424B5 MetaVia Inc. July 2, 2026 4:05 PM - SEC Filing Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing June 26, 2026 8:35 AM - StreetInsider Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - Globe NewsWire Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - StreetInsider Full Article List